share_log

方盛制药分红管理制度(已经2024年第二次临时股东大会审议通过)

Fangsheng Pharmaceutical\'s dividend management system (reviewed and approved by the 2nd Extraordinary General Meeting of Shareholders in 2024)

SZSI ·  Sep 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more